Semaglutide is usually demonstrated to acquire prospective kidney Positive aspects in T2D patients driven in part by its hypoglycemic and cardioprotective results [twelve].As a consequence of its reduction in blood glucose levels, semaglutide along with other GLP-1-RA’s can sometimes bring on hypoglycemic situations. However, this is unheard of a